IP Library Granted Patent US 6,953,575
Granted Patent B2
US 6,953,575 · App. 09/887,854 · Granted Oct 11, 2005

Methods of treating central nervous system disorders using viral vectors

Assignees: Avigen, Inc.; The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,953,575
App. No.
09/887,854
Granted
Oct 11, 2005
Kind
B2
Abstract

Methods of delivering viral vectors, particularly recombinant AAV virions, to the CNS are provided. Also provided are methods of treating Parkinson's Disease.

Claims (9)

1. A method of delivering recombinant adeno-associated virus virions to the brain of a subject suffering from a central nervous system (CNS) disorder, comprising:

(a) providing a composition comprising recombinant adeno-associated virus virions, said recombinant adeno-associated virus virions encoding a protein; and

(b) administering said composition to the brain of the subject such that distribution of said recombinant adeno-associated virus virions over an area greater than 5 mm 2 is achieved, wherein said recombinant adeno-associated virus virions are administered by convection enhanced delivery using a pump.

2. The method of claim 1 , wherein said convection enhanced delivery is performed using an infusion pump.

3. The method of claim 2 , wherein distribution of said recombinant adeno-associated virus virions is over an area of at least about 50 mm 2 .

4. The method of claim 1 , wherein said convection enhanced delivery is performed using an osmotic pump.

5. The method of claim 4 , wherein distribution of said recombinant adeno-associated virus virions is over an area of at least about 50 mm 2 .

6. The method of claim 1 , wherein said recombinant adeno-associated virus virions are administered to the striatum.

7. The method of claim 1 , wherein distribution of said recombinant adeno-associated virus virions is over an area of at least about 50 mm 2 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2007
From: AVIGEN, INC.
To: GENZYME CORPORATION
Reel/Frame 020010/0563 →
CONFIRMATORY LICENSE Recorded Jun 18, 2004
From: CALIFORNIA, UNIVERSITY OF
To: ENERGY, U.S. DEPARTMENT OF
Reel/Frame 014756/0736 →
Continuity (4)
Continuation 0932017100 · May 26, 1999
Provisional Application 6008694900 · May 27, 1998
Provisional Application 6013474800 · May 18, 1999
Related Publication 20020141980A1 · Oct 3, 2002